5%+ major-holding disclosures
- 제넥신17.56%2026-06-05 · 증감 +0.54%p
- 무림-블루웨이브 제2호 신기술투자조합7.09%2024-10-04 · 증감 +7.09%p
NeoImmuneTech
A950220 · KOSDAQ₩3,050+7.02%
2026-08-25 closeLoading chart…
Close
AI Insight
Why these signals fired — only backtest-proven edge, told honestly
New high + volume — the real recordrecord · not a prediction
Not this one stock, but every new-high-plus-volume pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-25)
Last 30 sessions
402 picks
Next-day win rate
51.6%
Avg next-day
-0.06%
vs market
-0.24%p
Beat the market on 45.3% of picks (each pick vs its own day’s market average).
Recent publish days (next-day win rate)
08-23 60%08-21 36.4%08-20 44.4%08-19 0%08-18 27.3%08-14 23.1%08-13 41.7%08-12 70%08-11 77.8%08-10 22.2%08-07 61.5%08-06 27.3%
This stock has not flashed this signal recently — the record above is the signal’s own, not this stock’s.
Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.
Trade plan
Decide the exit before you enter. Set what you are willing to lose first, and the share count follows — so you know the worst case before you buy.
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
This is a calculator, not advice, and it does not promise any outcome. You choose the stop and target — the button values (ATR, recent low/high) are observations from past prices. Actual fills depend on the order book and liquidity.
Key suppliers · Annual report
Annual reportDART · 2026-03-19Suppliers disclosed by the company in its 2026-03-19 annual report.
Suppliers without disclosed amount
Financials at a glance
NeoImmuneTech's latest results and balance sheet. The bars track the last three periods.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
Other stocks held by the same investors
A filing-based shared-holder record, not investment advice.
- 툴젠KRA199800 →
Shared holders: 제넥신
Connections
AI-extracted related companies · for reference
Competitors
한올바이오파마Price comovement r=0.20 (1 year)에이치엘비생명과학셀트리온Price comovement r=0.22 (1 year)AstraZenecaMerck & Co.Bristol Myers SquibbNovartisRochePfizerAmgenSanofiRegeneron PharmaceuticalsAbbVie
Recent filings
NeoImmuneTech's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
Like these rules? Run them automatically.
Quantus turns rules like these into backtests and automated trading — same team, free to start.
Quantus Signal · live data · not investment advice · Privacy Policy